Skip to main content
SpringerLink
Log in

Current perspectives in gliomas

  • Review
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The annual incidence of primary central nervous system tumors, including gliomas, is increasing, however, the prognosis of these tumors remains poor with a median survival of only 5 years. The imaging of tumors by computerised tomography, magnetic resonance imaging and newer methods such as positron emission tomography and proton magnetic resonance spectroscopy (1H-MRS) is increasing our knowledge of tumor biology and extent of the disease. Advances within the field of neurosurgery have improved operative procedures reducing mortality and morbidity. Furthermore, radiotherapy planning, tumor targeting and repositioning for treatment have all improved initial tumor management The role of adjuvant chemotherapy remains controversial. Chemotherapy for advanced and recurrent disease has been extensively investigated, and although improvements in quality of life have been recorded, no prolongation of survival has been documented. With new discoveries and increasing knowledge of the physiology and molecular biology of these tumors the potential for targeting therapy at a genetic level is becoming increasingly promising. This review provides an overview of these current perspectives in glioma management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greig, N.H., Ries, LG., Yancik, R. and Rapoport, S.I. (1990) Increasing annual incidence of primary malignant brain tumors in the elderly [see comments].J. Natl. Cancer Inst. 82(20), 1621–4.

    Article  PubMed  CAS  Google Scholar 

  2. OPCS. Cancer Statistics — Registrations (1988). Series MB1 1993; no. 21(HMSO).

  3. Burger, P.C., Scheithauer, B.W. and Vogel, F.S. (1991)Surgical Pathology of the Nervous System and its Coverings. 3rd edn. New York: Churchill Livingstone.

    Google Scholar 

  4. Svien, HJ., Mabon, R.F., Kernohan, J.W., and Adson, A.W. (1949) Astrocytomas.Proc. Staff. Meet. Mayo. Clin. 24, 54–64.

    CAS  Google Scholar 

  5. Kernohan, J.W., Mabon, R.F., Svien, H.J., and Adson, A.W. (1949) A simplified classification of gliomas.Proc. Staff Meet. Mayo Clin. 24, 71–5.

    CAS  Google Scholar 

  6. Ringertz, N. (1950) Grading of gliomas.Ada Pathol. Microbiol. Scand. 27, 51–64.

    CAS  Google Scholar 

  7. Nelson, J.S., Tsukada, Y., Schoenfeld, D., Fulling, K., Lamarche, J. and Peress, N. (1983) Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas.Cancer 52(3), 550–4.

    Article  PubMed  CAS  Google Scholar 

  8. Daumas Duport, C., Scheithauer, B., O’Fallon, J. and Kelly, P. (1988) Grading of astrocytomas. A simple and reproducible method.Cancer 62(10), 2152–65.

    Article  PubMed  CAS  Google Scholar 

  9. Kim, T.S., Halliday, A.L., Hedley Whyte, E.T. and Convery, K. (1991) Correlates of survival and the Daumas-Duport grading system for astrocytomas.J. Neurosurg. 74(1), 27–37.

    PubMed  CAS  Google Scholar 

  10. Kleihues, P., Burger, P.C. and Scheithauer, B.W. (1993) The new WHO classification of brain tumours.Brain Pathol. 3(3), 255–68.

    Article  PubMed  CAS  Google Scholar 

  11. Bruner, J.M. (1994) Neuropathology of Malignant Gliomas. (1994)Semin. Oncol. 21, 126–38.

    PubMed  CAS  Google Scholar 

  12. Krouwer, H.G., Davis, R.L., Silver, P. and Prados, M. (1991) Gemistocytic astrocytomas: a reappraisal.J. Neurosurg. 74(3), 399–406.

    PubMed  CAS  Google Scholar 

  13. Libermann, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, MD., Ullrich, A. and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain rumours of glial origin.Nature 313(5998), 144–7.

    Article  PubMed  CAS  Google Scholar 

  14. Wong, A.J., Ruppert, J.M., Bigner, S.H., Grzeschik, C.H., Humphrey, P.A., Bigner, D.S. and Vogelstein, B. (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas.Proc. Natl. Acad. Sci. USA 89(7), 2965–9.

    Article  PubMed  CAS  Google Scholar 

  15. Collins, V.P. and James, C.D. (1993) Gene and chromosomal alterations associated with the development of human gliomas.FASEB J. 7(10), 926–30.

    PubMed  CAS  Google Scholar 

  16. Ekstrand, A.J., James, C.D., Cavenee, W.K., Seliger, B., Pettersson, R.F. and Collins, V.P. (1991) Genes for epidermal growth, factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomasin vivo.Cancer Res. 51(8), 2164–72.

    PubMed  CAS  Google Scholar 

  17. Wong, A.J., Zoltick, P.W. and Moscatello, D.K. (1994) The molecular biology and molecular genetics of astrocytic neoplasms.Semin. Oncol. 21(2), 139–48.

    PubMed  CAS  Google Scholar 

  18. Takahashi, J.A., Fukumoto, M., Igarashi, K., Oda, Y., Kikuchi, H. and Hatanaka, M. (1992) Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas.J. Neiirosurg. 76(5), 792–8.

    CAS  Google Scholar 

  19. Plate, K.H., Breier, G., Farrell, C.L. and Risau, W. (1992) Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.Lab. Invest. 67(4), 529–34.

    PubMed  CAS  Google Scholar 

  20. Engebraaten, O., Bjerkvig, R., Pedersen, P.H. and Laerum, O.D. (1993) Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsiesin vitro.Int. J. Cancer 53(2), 209–14.

    Article  PubMed  CAS  Google Scholar 

  21. Ueba, T., Nosaka, T., Takahashi, J.A., Shibata, F., Florkiewicz, R.Z., Vogelstein, B., Oda, Y., Kikuchi, H. and Hatanaka, M. (1994) Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.Proc. Natl. Acad. Sci. USA 91(19), 9009–13.

    Article  PubMed  CAS  Google Scholar 

  22. Bigner, S.H., Burger, P.C., Wong, A.J., Werner, M.H., Hamilton, SR., Muhlbaier, L.H., Vogelstein, B. and Bigner, D.D. (1988) Gene amplification in malignant human gliomas: clinical and histopathologic aspects.J. Neuropathol. Exp. Neurol. 47(3), 191–205.

    Article  PubMed  CAS  Google Scholar 

  23. Li, F.P., Fraumeni, J.F., Mulvihill, J.J., Blather, W.A., Dreyfus, M.G., Tucker, MA. and Miller, R.M. (1988) A cancer family syndrome in twenty-four kindreds.Cancer Research 48, 5358–62.

    PubMed  CAS  Google Scholar 

  24. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F. Jr, Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A. and Friend, S.H. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms [see comments].Science 250(4985), 1233–8.

    Article  PubMed  CAS  Google Scholar 

  25. Toguchida, J., Yamaguchi, T., Dayton, S.H., Beauchamp, R.L., Herrera, G.E., Ishizaki, K., Yamamuro, T., Meyers, P.A., Little, J.B., Sasaki, M.S., Weichselbaum, R.R. and Yandell, D.W. (1992) Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma [see comments].N. Engl. J. Med. 326(20), 1301–8.

    Article  PubMed  CAS  Google Scholar 

  26. Levine, A.J., Perry, M.E., Chang, A., Silver, A., Dittmer, D., Wu, M. and Welsh, D. (1994) The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.Br. J. Cancer 69(3), 409–16.

    PubMed  CAS  Google Scholar 

  27. Karamitopoulou, E., Perentes, E. and Diamantis, I. (1993) p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.Acta Neuropathol. Berl. 85(6), 611–6.

    Article  PubMed  CAS  Google Scholar 

  28. del Arco, A., Garcia, J., Arribas, C, Barrio, R., Blazquez, MG., Izquierdo, J.M. and Izquierdo, M. (1993) Timing of p53 mutations during astrocytoma tumorigenesis.Hum. Mol. Genet. 2(10), 1687–90.

    Article  PubMed  Google Scholar 

  29. Rasheed, B.K., McLendon, R.E., Herndon, J.E., Friedman, H.S., Friedman, A.H., Bigner, D.D. and Bigner, S.H. (1994) Alterations of the TP53 gene in human gliomas.Cancer Res. 54(5), 1324–30.

    PubMed  CAS  Google Scholar 

  30. Fults, D., Brockmeyer, D., Tullous, M.W., Pedone, C.A. and Cawthon, R.M. (1992) p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.Cancer Res. 52(3), 674–9.

    PubMed  CAS  Google Scholar 

  31. Chozick, B.S., Weicker, M.E., Pezzullo, J.C, Jackson, C.L., Finkelstein, S.D., Ambler, M.W., Epstein, M.H. and Finch, P.W.(1994) Pattern of mutant p53 in human astrocytomas suggests the existence of alternate pathways of tumorigenesis.Cancer 73(2), 406–15.

    Article  PubMed  CAS  Google Scholar 

  32. Hamilton, S.R., Liu, B., Parsons, R.E., Papadopoulos, N., Jen, J., Powell, S.M., Krush, A.J., Berk, T., Cohen, Z., Tetu, B., Burger, P.C, Wood, P.A., Taqi, F., Booker, S.V., Petersen, G.M., Offerhaus, G.J.A., Tersmette, A.C., Giardiello, F.M., Vogelstein, B. and Kinzler, K. (1995) The molecular basis of Turcot’s syndrome [see comments].N. Engl. J. Med. 332(13), 839–47.

    Article  PubMed  CAS  Google Scholar 

  33. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M., Sargeant, L., Krapcho, K., Wolff, E., Randall, B., Hughes, J.P., Warrington, J., McPherson, J., Wasmuth, J., Le Paslier, D., Abderrahim, H., Cohen, D., Leppert, M. and White, R. (1991) Identification and characterization of the familial adenomatous polyposis coli gene.Cell 66(3), 58–600.

    Article  Google Scholar 

  34. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S. and Hedge, P. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.Science 53(5020), 665–9.

    Article  Google Scholar 

  35. Rubinfeld, B., Souza, B., Albert, I, Muller, O., Chamberlain, SH., Masiarz, F.R., Munemitsu, S. and Polakis, P. (1993) Association of the APC gene product with beta-catenin.Science 262(5140), 1731–4.

    Article  PubMed  CAS  Google Scholar 

  36. Su, L.K., Vogelstein, B. and Kinzler, K.W. (1993) Association of the APC tumor suppressor protein with catenins.Science 262(5140), 1734–7.

    Article  PubMed  CAS  Google Scholar 

  37. Peltomaki, P., Aaltonen, L.A., Sistonen, P., Pylkkanen, L., Mecklin, J.P., Jarvinen, H., Green, J.S., Jass, J.R., Weber, J.L., Leach, F.S., Petersen, G.M., Hamilton, S.R., de la Chapelle, A. and Vogelstein, B. (1993) Genetic mapping of a locus predisposing to human colorectal cancer [see comments].Science 260(5109), 810–2.

    Article  PubMed  CAS  Google Scholar 

  38. Lindblom, A., Tannergard, P., Werelius, B. and Nordenskjold, M. (1993) Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer.Nat. Genet. 5(3), 279–82.

    Article  PubMed  CAS  Google Scholar 

  39. Nicolaides, N.C, Papadopoulos, N., Liu, B., Wei, Y.F., Carter, K.C., Ruben, S.M., Rosen, C.A., Haseltine, W.A., Fleischmann, R.D., Fraser, C.M., Adams, M.D., Venter, J.C., Dunlop, M.G., Hamilton, S.R., Petersen, G.M. and de la Chapelle, A. (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.Nature 371(6492), 75–80.

    Article  PubMed  CAS  Google Scholar 

  40. Wallace, M.R., Marchuk, D.A., Andersen, L.B., Letcher, R., Odeh, H.M., Saulino, A.M., Fountain, J.W., Brereton, A., Nicholson, J., Mitchell, A.L., Brownstein, B.H. and Collins, F.S. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients [published erratum appears inScience 1990 Dec 21; 250(4988), 1749].Science 249(4965), 181–6.

    Article  PubMed  CAS  Google Scholar 

  41. Johnson, R.L., Rothman, A.L., Xie, J., Goodrich, L.V., Bare, J.W., Bonifas, J.M., Quinn, A.G., Myers, R.M., Cox, D.R., Epstein, E.H. Jr and Scott, M.P. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome.Science 272(5268), 1668–71.

    Article  PubMed  CAS  Google Scholar 

  42. Hahn, H., Christiansen, J., Wicking, C, Zaphiropoulos, P.G., Chidambaram, A., Gerrard, B., Vorechovsky, L, Bale, A.E., Toftgard, R., Dean, M. and Wainwright, B. (1996) A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities.J. Biol. Chem. 271(21), 12125–8.

    Article  PubMed  CAS  Google Scholar 

  43. Shilo, B.Z. (1996) Tumour suppressors. Dispatches from patched [news].Nature 382(6587), 115–6.

    Article  PubMed  CAS  Google Scholar 

  44. Jones, CE., Davis, M.B., Darling, J.L., Geddes, J.F., Thomas, D.G.T. and Harding, A.E. (1995) Loss of heterozygosity for DNA polymorphisms mapping to chromosomes 10 and 17 and prognosis in patients with gliomas.J. Neurol. Neurosurg. Psychiatry. 58, 218–21.

    Article  PubMed  CAS  Google Scholar 

  45. von Deimling, A., Nagel, J., Bender, B., Lenarrz, D., Schramm, J., Louis, D.N. and Wiestier, O.D. (1994) Deletion mapping of chromosome 19 in human gliomas.Int. J. Cancer 57(5), 676–80.

    Article  Google Scholar 

  46. Watanabe, K., Nagai, M, Wakai, S., Arai, T. and Kawashima, K. (1990) Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma.Acta Neuropathol. Berl. 80(3), 251–4.

    Article  PubMed  CAS  Google Scholar 

  47. Mikkelsen, T. (1994) Recent advances in brain tumor molecular biology.Curr. Opin. Oncol. 6(3), 229–34.

    Article  PubMed  CAS  Google Scholar 

  48. Pershouse, M.A., Stubblefield, E., Hadi, A., Killary, A.M., Yung, W.K. and Steck, P.A. (1993) Analysis of the functional role of chromosome 10 loss in human glioblastomas.Cancer Res. 53(20), 5043–50.

    PubMed  CAS  Google Scholar 

  49. Ye, Z., Qu, J.K. and Darras, B.T. (1993) Loss of heterozygosity for alleles on chromosome 10 in human brain tumours.Neurol. Res. 15(1), 59–62.

    PubMed  CAS  Google Scholar 

  50. Karlbom, A.E., James, C.D., Boethius, J., Cavenee, W.K., Collins, V.P., Nordenskjold, M. and Larsson, C. (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.Hum. Genet. 92(2), 169–74.

    Article  PubMed  CAS  Google Scholar 

  51. James, C.D., Karlbom, E., Dumanski, J.P., Hansen, M., Nordenskjold, M., Collins, V.P. and Cavenee, W.K. (1988) Clonal genomic alterations in glioma malignancy stages.Cancer Res. 48, 5546–51.

    PubMed  CAS  Google Scholar 

  52. James, C.D., He, J., Collins, V.P., Allalunis Turner, M.J. and Day, R.S. (1993) Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group.Cancer Res. 53(16), 3674–6.

    PubMed  CAS  Google Scholar 

  53. Olopade, O.I., Jenkins, R.B., Ransom, D.T., Malik, K., Pomykala, H., Nobori, T., Cowan, J.M., Rowley, J.D. and Diaz, M.O. (1992) Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.Cancer Res. 52(9), 2523–9.

    PubMed  CAS  Google Scholar 

  54. Fearon, E. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis.Cell 61(5), 759–67.

    Article  PubMed  CAS  Google Scholar 

  55. Bello, M.J., de Campos, J.M., Kusak, M.E., Vaquero, J., Sarasa, J.L., Pestana, A. and Rey, J.A. (1994) Molecular analysis of genomic abnormalities in human gliomas.Cancer Genet. Cytogenet. 73(2): 122–9.

    Article  PubMed  CAS  Google Scholar 

  56. Clurman, B.E. and Roberts, J.M. (1995) Cell cycle and cancer [editorial; comment].J. Natl. Cancer Inst. 87(20), 1499–501.

    Article  PubMed  CAS  Google Scholar 

  57. Schmidt, E.E., Ichimura, K., Reifenberger, G. and Collins, V.P. (1994) CDKN2 (p16/MTSl) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.Cancer Res. 54(24), 6321–4.

    PubMed  CAS  Google Scholar 

  58. Jen, J., Harper, J.W., Bigner, S.H., Bigner, D.D., Papadopoulos, N., Markowitz, S., Willson, J.K., Kinzler, K.W. and Vogelstein, B. (1994) Deletion of pl6 and pl5 genes in brain tumors.Cancer Res. 54(24), 6353–8.

    PubMed  CAS  Google Scholar 

  59. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E.E. and Collins, V.P. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.Cancer Res. 53(12), 2736–9.

    PubMed  CAS  Google Scholar 

  60. Chang, C.H., Horton, J., Schoenfeld, D., Salazer, O., Perez Tamayo, R., Kramer, S., Weinstein, A., Nelson, J.S. and Tsukada, Y. (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.Cancer 52(6), 997–1007.

    Article  PubMed  CAS  Google Scholar 

  61. Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party. (1990)J. Neurooncol. 9(1), 47–55.

    Article  Google Scholar 

  62. Han, J.S., Bonstelle, CT., Kaufman, B., Benson, J.E., Alfidi, R.J., Clampitt, M., Van Dyke, C., Huss, R.G. (1984) Magnetic resonance imaging in the evaluation of the brainstem.Radiology 150(3): 705–12.

    PubMed  CAS  Google Scholar 

  63. Wroe, S.J., Foy, P.M., Shaw, M.D., Williams, I.R., Chadwick, D.W., West, C. and Towns, G. (1986) Neurological and neurosurgical approaches in the management of malignant brain tumours [letter].Br. Med. J. Clin. Res. Ed. 293(6558), 1373.

    PubMed  CAS  Google Scholar 

  64. Chamberlain, M.C., Murovic, J.A. and Levin, V.A. (1988) Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas [published erratum appears inNeurology 1988 Nov;38(ll), 1816].Neurology 38(9), 1371–4.

    PubMed  CAS  Google Scholar 

  65. Pedersen, H., Gjerris, F. and Klinken, L. (1989) Malignancy criteria in computed tomography of primary supratentorial tumors in infancy and childhood.Neuroradiology 31(1), 24–8.

    PubMed  CAS  Google Scholar 

  66. Gruber, M.L. and Hochberg, F.H. (1990) Systematic evaluation of primary brain rumors [comment].J. Nucl. Med. 31(6), 969–71.

    PubMed  CAS  Google Scholar 

  67. Caimcross, J.G., Pexman, J.H., Rathbone, M.P. and Del-Maestro, R.F. (1985) Postoperative contrast enhancement in patients with brain tumor.Ann. Neurol. 17(6), 570–2.

    Article  Google Scholar 

  68. Jeffries, B.F., Kishores, P.R., Singh, K.S., Ghatak, N.R. and Krempa, J. (1981) Contrast enhancement in the postoperative brain.Radiology 139(2), 409–13.

    PubMed  CAS  Google Scholar 

  69. Cairncross, J.G., Macdonald, D.R., Pexman, J.H. and Ives, F.J. (1988) Steroid-induced CT changes in patients with recurrent malignant glioma.Neurology 38(5), 724–6.

    PubMed  CAS  Google Scholar 

  70. Brooks, DJ., Beaney, R.P., Lammertsma, A.A., Leenders, K.L., Horlock, P.L., Kensett, M.J., Marshall, J., Thomas, D.G. and Jones, T. (1984) Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography.J. Cereb. Blood Flow Metab. 4(4), 535–45

    PubMed  CAS  Google Scholar 

  71. Di Chiro, G., DeLaPaz, R.L., Brooks, R.A., Sokoloff, L., Kornblith, P.L., Smith, B.H., Patronas, N.J., Kufta, C.V., Kessler, R.M., Johnston, G.S., Manning, R.G. and Wolf, A.P. (1982) Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.Neurology 32(12), 1323–9.

    PubMed  Google Scholar 

  72. Francavilla, T.L., Miletich, R.S., Di Chiro, G., Parronas, N.J., Rizzoli, H.V. and Wright, D.C. (1989) Positron emission tomography in the detection of malignant degeneration of low-grade gliomas.Neurosurgery 24(1), 1–5.

    Article  PubMed  CAS  Google Scholar 

  73. Patronas, N.J., Brooks, R.A., DeLaPaz, R.L., Smith, B.H., Kornblith, P.L. and Di Chiro G. (1983) Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas.AJNR Am. J. Neuroradiol. 4(3), 533–5.

    PubMed  CAS  Google Scholar 

  74. Di Chiro, G., Oldfield, E., Wright, D.C, De Michele, D., Katz, D.A., Patronas, N.J., Doppman, J.L., Larson, S.M., Ito, M. and Kufta, C.V. (1988) Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain rumors: PET and neuropathologic studies.AJR Am. J. Roentgenol. 150(1), 189–97.

    PubMed  Google Scholar 

  75. Patronas, NJ., Di Chiro, G., Brooks, R.A., DeLaPaz, R.L., Kornblith, P.L., Smith, B.H., Rizzoli, H.V., Kessler, R.M., Manning, R.G., Channing, M., Wolf, A.P. and O’Connor, C.M. (1982) Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.Radiology 144(4): 885–9.

    PubMed  CAS  Google Scholar 

  76. Valk, P.E., Budinger, T.F., Levin, V.A., Silver, P., Gutin, P.H. and Doyle, W.K. (1988) PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.J. Neurosurg. 69(6), 830–8.

    PubMed  CAS  Google Scholar 

  77. Wahl, R.L., Zasadny, K., Helvie, M., Hutchins, G.D., Weber, B. and Cody, R. (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.J. Clin. Oncol. 11(11), 2101–11.

    PubMed  CAS  Google Scholar 

  78. Jansson, T., Westlin, J.E., Ahlstrom, H., Lilja, A., Langstrom, B. and Bergh, J. (1995) Positron emission tomography studies in patients with locally advanced and/or meta-static breast cancer: a method for early therapy evaluation?J. Clin. Oncol. 13(6), 1470–7.

    PubMed  CAS  Google Scholar 

  79. Holthoff, V.A., Herholz, K., Berthold, F., Widemann, B., Schroder, R., Neubauer, I. and Heiss, W.D. (1993)In vivo metabolism of childhood posterior fossa rumors and primitive neuroectodermal tumors before and after treatment.Cancer 72(4), 1394–403.

    Article  PubMed  CAS  Google Scholar 

  80. Alavi, J.B., Alavi, A., Chawiuk, J., Kushner, M., Powe, J., Hickey, W. and Reivich, M. (1988) Positron emission tomography in patients with glioma. A predictor of prognosis.Cancer 62(6), 1074–8.

    Article  PubMed  CAS  Google Scholar 

  81. Patronas, N.J., Di Chiro, G., Kufta, C., Bairamian, D., Kornblith, P.L., Simon, R. and Larson, S.M. (1985) Prediction of survival in glioma patients by means of positron emission tomography.J. Neurosurg. 62(6), 816–22.

    PubMed  CAS  Google Scholar 

  82. Fulham, M.J., Bizzi, A., Dietz, M.J., Shih, H.H., Raman, R., Sobering, G.S., Frank, J.A., Dwyer, A.J., Alger, J.R. and Di Chiro, G. (1992) Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.Radiology 185(3), 675–86.

    PubMed  CAS  Google Scholar 

  83. Preul, M.C., Caramanos, Z., Collins, D.L., Villemure, J.-G., Leblanc, R., Olivier, A., Pokrupa, R. and Arnold, D.L. (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.Nature Med. 2(3), 323–5.

    Article  PubMed  CAS  Google Scholar 

  84. Kugel, H., Heindel, W., Ernestus, R.I., Bunke, J., du Mesnil, R. and Friedmann G. (1992) Human brain tumors: spectral patterns detected with localized H-l MR spectroscopy.Radiology 183(3), 701–9.

    PubMed  CAS  Google Scholar 

  85. Ott, D., Hennig, J. and Ernst, T. (1993) Human brain rumors: assessment within vivo proton MR spectroscopy.Radiology 186(3), 745–52.

    PubMed  CAS  Google Scholar 

  86. Thomas, D.G. and Nouby, R.M. (1989) Experience in 300 cases of CT-directed stereotactic surgery for lesion biopsy and aspiration of haematoma.Br. J. Neurosurg. 3(3), 321–5.

    Article  PubMed  CAS  Google Scholar 

  87. Edwards, M.S., Boggan, J.E. and Fuller, TA. (1983) The laser in neurological surgery.J. Neurosurg. 59(4), 555–66.

    PubMed  CAS  Google Scholar 

  88. Ammirati M., Vick, N., Liao, Y.L., Ciric, I. and Mikhael, M. (1987) Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.Neurosurgeny 21(2), 201–6.

    CAS  Google Scholar 

  89. Winger, M.J., Macdonald, D.R. and Cairncross, J.G. (1989) Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior lowgrade glioma.J. Neurosurg. 71(4), 487–93.

    PubMed  CAS  Google Scholar 

  90. Wood, J.R., Green, S.B. and Shapiro, W.R. (1988) The prognostic importance of rumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.J. Clin. Oncol. 6(2), 338–43.

    PubMed  CAS  Google Scholar 

  91. Walker, M.D., Alexander, E. Jr, Hunt, W.E., MacCarty, C.S., Mahaley, M.S. Jr, Mealey, J. Jr, Norrell, H.A., Owens, G., Ransohoff, J., Wilson, C.B., Gehan, E.A. and Strike, T.A. (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.J. Neurosurg. 49(3), 333–43.

    PubMed  CAS  Google Scholar 

  92. Walker, M.D., Green, S.B., Byar, D.P., Alexander, E. Jr, Batzdorf, U., Brooks, W.H., Hunt, W.E., MacCarty, C.S., Mahaley, M.S. Jr, Mealey, J. Jr, Owens, G., Ransohoff, J.D., Robertson, J.T., Shapiro, W.R., Smith, K.R. Jr, Wilson, CB. and Strike, T.A. (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.N. Engl. J. Med. 303(23), 1323–9.

    PubMed  CAS  Google Scholar 

  93. Hochberg, F.H. and Pruitt, A. (1980) Assumptions in the radiotherapy of glioblastoma.Neurology 30(9), 907–11.

    PubMed  CAS  Google Scholar 

  94. McComb, R.D. and Burger, P.C. (1985) Pathologic analysis of primary brain tumors.Neurol. Clin. 3(4), 711–28.

    PubMed  CAS  Google Scholar 

  95. Walker, M.D., Strike, T.A. and Sheline, G.E. (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas.Int. J. Radiat. Oncol. Biol. Phys. 5(10), 1725–31.

    PubMed  CAS  Google Scholar 

  96. Bleehen, N.M. and Stenning, S.P. (1991) A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.Br. J. Cancer 64(4), 769–74.

    PubMed  CAS  Google Scholar 

  97. Brada, M., Thomas, G., Elyan, S., James, N., Hines, F., Ashley, S., Marsh, H., Bell, B.A. and Stenning, S. (1995) Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.Br. J. Cancer 71, 1330–1334

    PubMed  CAS  Google Scholar 

  98. Keim, H., Potthoff, P.C., Schmidt, K., Schiebusch, M., Neiss, A. and Trott, K.R. (1987) Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.Radiother. Oncol. 9(1), 21–6.

    Article  PubMed  CAS  Google Scholar 

  99. Fulton, D.S., Urtasun, R.C., Scott Brown, I., Johnson, E.S., Mielke, B., Curry, B., Huyser Wierenga, D., Hanson, J. and Feldstein, M. (1992) Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study.J. Neurooncol. 14, 63–72.

    Article  PubMed  CAS  Google Scholar 

  100. Shrieve, D.C., Wara, W.M., Edwards, M.S., Sneed, P.K., Prados, M.D., Cogen, P.H., Larson, D.A. and Levin, V.A. (1992) Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults.Int. J. Radiat. Oncol. Biol. Phys. 24(4), 599–610.

    PubMed  CAS  Google Scholar 

  101. Nelson, D.F., Curran, W.J. Jr, Scott, C., Nelson, J.S., Weinstein, A.S., Ahmad, K., Constine, L.S., Murray, K., Powlis, W.D., Mohiuddin, M. and Fischbach, J. (1993) Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma — possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.Int. J. Radiat. Oncol. Biol. Phys. 25, 193–207.

    PubMed  CAS  Google Scholar 

  102. Deutsch, M., Green, S.B., Strike, T.A., Burger, P.C., Robertson, J.T., Selker, R.G., Shapiro, W.R., Mealey, J. Jr, Ransohoff, J.D., Paoletti, P., Smith, K.R. Jr, Odom, G.L., Hunt, W.E., Young, B., Alexander, E. Jr, Walker, M.D. and Pistenmaa, D.A. (1989) Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.Int. J. Radiat. Oncol. Biol. Phys. 16(6), 1389–96.

    PubMed  CAS  Google Scholar 

  103. Loeffler, J.S., Siddon, R.L., Wen, P.Y., Nedzi, L.A. and Alexander, E. (1990) Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects.Radiother. Oncol. 17, 311–21.

    Article  PubMed  CAS  Google Scholar 

  104. Chamberlain, M.C., Barba, D., Kormanik, P. and Shea, W.M. (1994) Stereotactic radiosurgery for recurrent gliomas.Cancer 74: 1342–7.

    Article  PubMed  CAS  Google Scholar 

  105. Sarkaria, J.N., Mehta, M.P., Loeffler, J.S., Buatti, J.M., Chappell, R.J., Levin, A.B., Alexander, E., Friedman, W.A. and Kinsella, T.J. (1995) Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.Int. J. Radiat. Oncol. Biol. Phys. 32(4), 931–41.

    PubMed  CAS  Google Scholar 

  106. Pan, D.H., Guo, W.Y., Chung, W.Y., Shiau, C.Y., Liu, R.S. and Lee, L.S. (1995) Early effects of Gamma Knife surgery on malignant and benign intracranial tumors.Stereotact. Fund. Neurosurg. 64 Suppl 1, 19–31.

    Article  Google Scholar 

  107. Laws, E.R. Jr, Cortese, D.A., Kinsey, J.H., Eagan, R.T. and Anderson, R.E. (1981) Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study.Neurosurgery 9(6), 672–8.

    Article  PubMed  Google Scholar 

  108. EORTC Brain Tumour Group. (1983) Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.Eur. J. Cancer Clin. Oncol. 19(1), 39–42.

    Article  Google Scholar 

  109. Nelson, D.F., Schoenfeld, D., Weinstein, A.S., Nelson, J.S., Wasserman, T., Goodman, R.L. and Carabell, S. (1983) A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.Int. J. Radiat. Oncol. Biol. Phys. 9(8), 1143–51.

    PubMed  CAS  Google Scholar 

  110. Bleehen, N.M. (1980) The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.Cancer Clin. Trials 3(3), 267–73.

    PubMed  CAS  Google Scholar 

  111. Fulton, D.S., Urtasun, R.C., Shin, K.H., Geggie, P.H., Thomas, H., Muller, P.J., Moody, J., Tanasichuk, H., Mielke, B., Johnson, E. and Curry, B. (1984) Misonidazole combined with hyperfractionation in the management of malignant glioma.Int. J. Radiat. Oncol. Biol. Phys. 10, 1709–12.

    PubMed  CAS  Google Scholar 

  112. Duncan, W. (1994) An evaluation of the results of neutron therapy trials.Acta Oncol. 33(3), 299–306.

    Article  PubMed  CAS  Google Scholar 

  113. Philips, T.L., Levin, V.A., Ahn, D.K., Gutin, P.H., Davis, R.L., Wilson, C.B., Prados, M.D., Wara, W.M. and Flam, M.S. (1991) Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study [see comments].Int. J. Radiat. Oncol. Biol. Phys. 21(3), 709–14.

    Google Scholar 

  114. Jackson, D., Kinsella, T., Rowland, J., Wright, D., Katz, D., Main, D., Collins, J., Kornblith, P. and Glatstein, E. (1987) Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.Am. J. Clin. Oncol. 10, 437–81.

    Article  PubMed  CAS  Google Scholar 

  115. Laing, R.W., Warrington, A.P., Graham, J., Britton, J., Hines, F. and Brada, M. (1993) Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).Radiother. Oncol. 27. 22–9.

    Article  PubMed  CAS  Google Scholar 

  116. Loeffler, J.S., Alexander, E.D., Wen, P.Y., Shea, W.M., Coleman, C.N., Kooy, H.M., Fine, H.A., Nedzi, L.A., Silver, B., Riese, N.E. and Black, P.M.L. (1990) Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.J. Natl. Cancer Inst. 82, 1918–21.

    Article  PubMed  CAS  Google Scholar 

  117. Gutin, P.H., Leibel, S.A., Wara, W.M., Choucair, A., Levin, V.A., Philips, T.L., Silver, P., Da Silva, V., Edwards, M.S., Davis, R.L., Weaver, K.A. and Lamb, S. (1987) Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources [published erratum appears inJ. Neurosurg. 1988 June; 68(6), 990].J. Neurosurg. 67(6), 864–73.

    PubMed  CAS  Google Scholar 

  118. Dische, S. (1991) A review of hypoxic cell radiosensitization.Int. J. Radiat. Oncol. Biol. Phys. 20(1), 147–52.

    PubMed  CAS  Google Scholar 

  119. Shapiro, J.R., Pu, P.Y., Mohamed, A.N., Galicich, J.H., Ebrahim, S.A. and Shapiro, W.R. (1993) Chromosome number and carmustine sensitivity in human gliomas.Cancer 71(12), 4007–21.

    Article  PubMed  CAS  Google Scholar 

  120. Fine, H.A., Dear, K.B., Loeffler, J.S., Black, P.M. and Canellos, G.P. (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults [see comments].Cancer 71(8), 2585–97.

    Article  PubMed  CAS  Google Scholar 

  121. Stenning, S.P., Freedman, L.S. and Bleehen, N.M. (1987) An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma [letter].Br. J. Cancer 56(1), 89–90.

    PubMed  CAS  Google Scholar 

  122. Tait, D.M., Thornton Jones, H., Bloom, HJ., Lemerle, J. and Morris Jones, P. (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).Eur. J. Cancer 26(4), 464–9.

    PubMed  CAS  Google Scholar 

  123. Evans, A.E., Jenkin, R.D., Sposto, R., Ortega, J.A., Wilson, C.B., Wara, W., Ertel, I.J., Kramer, S., Chang, C.H., Leikin, S.L. and Hammond, G.D. (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.J. Neurosurg. 72(4), 572–82.

    PubMed  CAS  Google Scholar 

  124. Levin, V.A., Silver, P., Hannigan, J., Wara, W.M., Gutin, P.H., Davis, R.L. and Wilson, C.B. (1990) Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.Int. J. Radiat. Oncol. Biol. Phys. 18(2), 321–4.

    PubMed  CAS  Google Scholar 

  125. Levin, V.A., Prados, M.R., Wara, W.M., Davis, R.L., Gutin, P.H., Phillips, T.L., Lamborn, K. and Wilson, C.B. (1995) Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.Int. J. Radiat. Oncol. Biol. Phys. 32(1), 75–83.

    PubMed  CAS  Google Scholar 

  126. Fingert, HJ. and Hochberg, F.H. (1984) Megadose chemotherapy with bone marrow rescue.Prog. Exp. Tumor Res. 28, 67–78.

    PubMed  CAS  Google Scholar 

  127. Mbidde, E.K., Selby, P.J., Perren, T.J., Dearnaley, D.P., Whitton, A., Ashley, S., Workman, P., Bloom, H.J. and McElwain, T.J. (1988) High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.Br. J. Cancer 58(6), 779–82.

    PubMed  CAS  Google Scholar 

  128. Fine, H.A. and Antman, K.H. (1992) High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.Bone Marrow Transplant 10(4), 315–21.

    PubMed  CAS  Google Scholar 

  129. Garfield, J. and Dayan, A.D. (1973) Postoperative intracavitary chemotherapy of malignant gliomas. A preliminary study using methotrexate.J. Neurosurg. 39(3), 315–22.

    PubMed  CAS  Google Scholar 

  130. Garfield, J., Dayan, A.D. and Weiler, R.O. (1975) Postoperative intracavitary chemotherapy of malignant supratentorial astrocytomas using BCNU.Clin. Oncol. 1(3), 213–22.

    PubMed  CAS  Google Scholar 

  131. Bouvier, G., Penn, R.D., Kroin, J.S., Beique, R. and Guerard, M.J. (1987) Direct delivery of medication into a brain tumor through multiple chronically implanted catheters.Neurosurgery 20(2), 286–91.

    Article  PubMed  CAS  Google Scholar 

  132. Nierenberg, D., Harbaugh, R., Maurer, L.H., Reeder, T., Scott, G., Fratkin, J. and Newman, E. (1991) Continuous intratumoral infusion of methotrexate for recurrent glioblastoma: a pilot study.Neuwsurgery 28(5), 752–61.

    Article  CAS  Google Scholar 

  133. Brem, K, Mahaley, M.S. Jr, Vick, N.A., Black, K.L., Schold, S.C. Jr, Burger, P.C., Friedman, A.H., Ciric, I.S., Eller, T.W., Cozzens, J.W. and Kenealy, J.N. (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.J. Neurosurg. 74(3), 441–6.

    PubMed  CAS  Google Scholar 

  134. Brem, H., Ewend, M.G., Piantadosi, S., Greenhoot, J., Burger, P.C. and Sisti, M. (1995) The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.J. Neurooncol. 26(2), 111–23.

    Article  PubMed  CAS  Google Scholar 

  135. O’Reilly, S.M., Newlands, E.S., Glaser, M.G., Brampton, M., Rice Edwards, J.M., Illingworth, R.D., Richards, P.G., Kennard, C., Colquhoun, I.R., Lewis, P. and Stevens, M.F.G. (1993) Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours [published erratum appears inEur. J. Cancer 1993;29A(10), 1500].Eur. J. Cancer 29a(7): 940–2.

    Article  PubMed  CAS  Google Scholar 

  136. Lesser, G.J. and Grossman, S. (1994) The chemotherapy of high-grade astrocytomas.Semin. Oncol. 21(2), 220–35.

    PubMed  CAS  Google Scholar 

  137. Tishler, R.B., Geard, C.R., Hall, E.J. and Schiff, P.B. (1992) Taxol sensitizes human astrocytoma cells to radiation.Cancer Res. 52(12), 3495–7.

    PubMed  CAS  Google Scholar 

  138. Tishler, R.B., Schiff, P.B., Geard, C.R. and Hall, E.J. (1992) Taxol: a novel radiation sensitizer.Int. J. Radiat. Oncol. Biol. Phys. 22(3), 613–7.

    PubMed  CAS  Google Scholar 

  139. Hei, T.K. and Hall, E.J. (1993) Taxol, radiation, and oncogenic transformation.Cancer Res. 53(6), 1368–72.

    PubMed  CAS  Google Scholar 

  140. Culver, K.W. and Blaese, R.M. (1994) Gene therapy for cancer.Trends Genet. 10(5), 174–8.

    Article  PubMed  CAS  Google Scholar 

  141. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H. and Blaese, R.M. (1992)In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors [see comments].Science 256(5063), 1552–2.

    Article  Google Scholar 

  142. Yu, J.S., Wei, MX, Chiocca, E.A., Martuza, R.L. and Tepper, R.I. (1993) Treatment of glioma by engineered interleukin 4-secreting cells.Cancer Res. 53(13), 3125–8.

    PubMed  CAS  Google Scholar 

  143. Morrison, R.S., Giordano, S., Yamaguchi, F., Hendrickson, S., Berger, M.S. and Palczewski, K. (1993) Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells.J. Neurosci. Res. 34(5), 502–9.

    Article  PubMed  CAS  Google Scholar 

  144. Ciric, I., Ammirati, M., Vick, N. and Mikhael, M. (1987) Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection.Neurosurgery 21(1), 21–6.

    Article  PubMed  CAS  Google Scholar 

  145. Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., Filiberti, A., Hechtner, H., Fleishman, S.B., de Haes, J.C., Kaasa, S., Klee, M., Osaba, D., Razavi, D., Rofe, P.B., Schraub, S., Sneeuw, K., Sullivan, M. and Takeda, F. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.J. Natl. Cancer Inst. 85(5), 365–76.

    Article  PubMed  CAS  Google Scholar 

  146. Newlands, E.S., Blackledge, G.R., Slack, J.A., Rustin, G.J., Smith, D.B., Stuart, N.S., Quarterman, C.P., Hoffman, R., Stevens, M.F., Brampton, M.H. and Gibson, A.C. (1992) Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).Br. J. Cancer 65(2), 287–91.

    PubMed  CAS  Google Scholar 

  147. Vasantha Kumar, A.R., Renaudin, J., Wilson, C.B., Boldrey, E.B., Enot, K.J. and Levin, V.A. (1974) Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study.J. Neurosurg. 40(3), 365–71.

    PubMed  CAS  Google Scholar 

  148. Stewart, D.J., Grahovac, Z., Hugenholtz, H., Russell, N., Richard, M. and Benoit, B. (1987) Combined intraarterial and systemic chemotherapy for intracerebral tumors.Neuwsurgery 21(2), 207–14.

    CAS  Google Scholar 

  149. Mahaley, M.S. Jr, Hipp, S.W., Dropcho, E.J., Bertsch, L., Cush, S., Tirey, T. and Gillespie, G.Y. (1989) Intracarond cisplarin chemotherapy for recurrent gliomas.J. Neurosurg. 70(3), 371–8.

    PubMed  Google Scholar 

  150. Longee, D.C., Friedman, H.S., Albright, R.E. Jr, Burger, P.C., Oakes, W.J., Moore, J.O. and Schold, S.C. Jr. (1990) Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine.J. Neurosurg. 72(4), 583–8.

    PubMed  CAS  Google Scholar 

  151. Yung, W.K., Mechtler, L. and Gleason, M.J. (1991) Intravenous carboplatin for recurrent malignant glioma: a phase II study.J. Clin. Oncol. 9(5), 860–4.

    PubMed  CAS  Google Scholar 

  152. Frenay, M., Giroux, B., Khoury, S., Derlon, J.M. and Namer, M. (1991) Phase II study of fotemustine in recurrent supratentorial malignant gliomas.Eur. J. Cancer 27(7), 852–6.

    Article  PubMed  CAS  Google Scholar 

  153. Gumerlock, M.K., Belshe, B.D., Madsen, R. and Watts, C. (1992) Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review.J. Neurooncol. 12(1), 33–46.

    Article  PubMed  CAS  Google Scholar 

  154. Dropcho, E.J., Rosenfeld, S.S., Morawetz, R.B., Vitek, J., Brothers, M., Gorum, T., Bell, S., Gillespie, G.Y., Glantz, M., Mahaley, M.S. Jr. and Schold, S.C. Jr. (1992) Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium.J. Clin. Oncol. 10(3), 452–8.

    PubMed  CAS  Google Scholar 

  155. Priestman, T.J., Bleehen, N.M., Rampling, R., Stenning, S., Nethersell, A.J. and Scott, J. (1993) A phase II evaluation of human lymphoblastoid interferon (Wellferon) in relapsed high grade malignant glioma. Medical Research Council Brain Tumour Working Party.Clin. Oncol. R. Coll. Radiol. 5(3), 165–8.

    PubMed  CAS  Google Scholar 

  156. Cairncross, G., Macdonald, D., Ludwin, S., Lee, D., Cascino, T., Buckner, J., Fulton, D., Dropcho, E., Stewart, D., Schold, C. Jr, Wainman, N. and Eisenhauer, E. (1994) Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.J. Clin. Oncol. 12(10), 2013–21.

    PubMed  CAS  Google Scholar 

  157. Stewart, DJ., Dahrouge, S. and Soltys, K. (1995) A phase II study of 5-fluorouraciI plus folinic acid in malignant gliomas in adults.J. Neurooncol. 23(3), 249–52.

    Article  PubMed  CAS  Google Scholar 

  158. Brem, H., Piantadosi, S., Burger, P.C., Walker, M., Selker, R., Vick, N.A., Black, K., Sisti, M., Brem, S., Mohr, G., Muller, P., Morawetz, R. and Schold, S.C. (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group [see comments].Lancet 345(8956), 1008–12.

    Article  PubMed  CAS  Google Scholar 

  159. Couldwell, W.T., Hinton, D.R., Surnock, A.A., DeGiorgio, CM., Weiner, L.P., Apuzzo, M.L.J., Masri, L., Law, R.E. and Weiss, M.H. (1996) Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen.Clin. Cancer Res. 2, 619–22.

    PubMed  CAS  Google Scholar 

  160. Sanson, M., Ameri, A., Monjour, A., Sahmoud, T., Ronchin, P., Poisson, P. and Delattre, J.Y. (1996) Treatment of recurrent malignant supratentorial gliomas with ifosfamide, Carboplatin and Etoposide: a phase II study.Eur. J. Cancer 32A(13), 2229–35.

    Article  PubMed  CAS  Google Scholar 

  161. Yung, W.K.A., Kyritsis, A.P., Gleason, M.J. and Levin, V.A. (1996) Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.Clin. Cancer Res. 2, 1931–5.

    PubMed  CAS  Google Scholar 

  162. Chauveinc, L., Sola Martinez, M.T., Martin Duvemeuil, M., Mazeron, J.J., Faillot, T., Cornu, P., Capelle, L., Delattre, J.Y., Poisson, M., Baillet, F. and Chiras, J. (1996) Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.J. Neurooncol. 27(2), 141–7.

    Article  PubMed  CAS  Google Scholar 

  163. Hildebrand, J., Sahmoud, T., Mignolet, F., Brucher, J.M. and Afra, D. (1994) Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group.Neurology 44(8), 1479–83.

    PubMed  CAS  Google Scholar 

  164. Shapiro, W.R., Green, S.B., Burger, P.C., Selker, R., VanGilder J.C., Robertson, J.T., Mealey, J. Jr, Ranshoff, J. and Mahaley, M.S. Jr. (1992) A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.J. Neurosurg. 76(5), 772–81.

    PubMed  CAS  Google Scholar 

  165. Barba, D., Saris, S.C., Holder, C., Rosenberg, S.A. and Oldfield, E.H. (1989) Intrarumoral LAK cell and inter-leukin-2 therapy of human gliomas. J. Neurosurg.70(2), 175–82.

    PubMed  CAS  Google Scholar 

  166. Riva, P., Arista, A., Tison, V., Sturiale, C, Franceschi, G., Spinelli, A., Riva, N., Casi, M., Moscatelli, G. and Frattarelli, M. (1994) Intralesionai radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors.Cancer 73(3 Suppl), 1076–82.

    Article  PubMed  CAS  Google Scholar 

  167. Stragliotto, G., Vega, F., Stasiecki, P., Gropp, P., Poisson, M. and Delattre, J.Y. (1996) Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas.Eur. J. Cancer 32a(4), 636–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology Unit, Charing Cross Hospital, Fulham Palace Road, W6 8RF, London, UK

    C. S. Brock & M. Bower

Authors
  1. C. S. Brock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bower
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brock, C.S., Bower, M. Current perspectives in gliomas. Med Oncol 14, 103–120 (1997). https://doi.org/10.1007/BF02990955

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02990955

Keywords

Search

Navigation